2017
BOTHELL, Washington, 14 December 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how...
Bothell, WA, 13 December 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how...
London, UK, 11 December 2017 Based on experience with 1000 patients over 15 years, the largest single-centre, prospective centre cohort of patients with HCC treated with Y90 glass microspheres BTG...
27 November 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces the appointment of Gregory Barrett as a non-executive director of the Board. Greg has a broad range...
16 November 2017 BTG plc (LSE: BTG), the global specialist healthcare company, announces the publication of new consensus guidelines for use of Voraxaze® (glucarpidase) in patients with high-dose...
London, UK, 14 November 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces its interim results for the six months ended 30 September 2017. Click here to download...
London, UK, 14 November 2017 BTG plc: Directorate change – Chief Financial Officer BTG plc (LSE: BTG), the global specialist healthcare company, announces that after 10 years as Chief Financial...
London, UK, 06 November 2017 BTG plc (LSE: BTG), the global specialist healthcare company, announces that the Court of Chancery of Delaware has issued its final order and judgement in relation to...
London, UK, 06 November 2017 BTG plc (LSE: BTG), the global specialist healthcare company, notes that the US Centers for Medicare and Medicaid Services have published the final fee schedule for...
London, UK, 09 October 2017 Researchers from the UCL Cancer Institute and the specialist healthcare company BTG plc (LSE: BTG) have begun the first clinical trial of an experimental treatment for...
London, UK, 05 October 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Roxwood Medical (“Roxwood”), an innovative provider of advanced...
London, UK, 05 October 2017 BTG plc (LSE: BTG), the global specialist healthcare company, provides the following update for the six months ended 30 September 2017 ahead of publication of its...
London, UK, 27 September 2017 Mirada Medical Ltd, a global medical imaging software company, has signed a three-year master service agreement with BTG plc (LSE: BTG), a global specialist...
London, UK, 20 September 2017 BTG plc (LSE: BTG), the global specialist healthcare company, announces that a Memorandum Opinion has been issued by the Court of Chancery of Delaware ruling against...
13 September 2017 BTG plc (LSE: BTG), the global specialist healthcare company, announces the inclusion of two of its oncology-related antidote products in the revised ‘Expert Consensus...
N/A, 21 August 2017 Total grant funding available for investigators has been doubled BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO),...
Vancouver, Canada, 25 July 2017 BTG International Canada Inc., part of global specialist healthcare company BTG, today announced EVA Vein Care is the first clinic in Vancouver and the surrounding...
London, UK, 13 July 2017 BTG plc (LSE: BTG), the global specialist healthcare company, provides the following update ahead of its Annual General Meeting, which is being held today at 10.30am at...
Bothell, WA, 16 June 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
West Conshohocken, PA, 13 June 2017 A study sponsored by BTG plc (LSE: BTG), the global specialist healthcare company, has been recently published in the Annals of Emergency Medicine (AEM) that...
London, UK, 10 June 2017 BTG plc (LSE: BTG), a global specialist healthcare company, today announced the results of a pilot study evaluating the effectiveness of a digital patient engagement...
Washington, DC, 07 June 2017 The Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, and global specialist healthcare...
Bothell, Washington, 22 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society...
#, 19 May 2017 Data from a pilot study using IO Loop™ with TheraSphere® (a Y90 transarterial radioembolisation therapy) will be presented at the World Conference on Interventional Oncology BTG...
London, UK, 16 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces its final results for the year ended 31 March 2017. Click here to download the results release...